PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group

PACS Group (NYSE:PACSGet Free Report) had its price objective lifted by investment analysts at UBS Group from $42.00 to $44.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target would indicate a potential upside of 15.42% from the stock’s current price.

Several other research firms have also issued reports on PACS. Zacks Research raised shares of PACS Group from a “strong sell” rating to a “hold” rating in a research report on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of PACS Group in a report on Monday, December 22nd. Oppenheimer boosted their target price on shares of PACS Group from $40.00 to $42.00 and gave the company an “outperform” rating in a report on Wednesday. Wall Street Zen upgraded PACS Group from a “hold” rating to a “buy” rating in a research report on Sunday, February 15th. Finally, Truist Financial set a $40.00 price target on PACS Group in a report on Friday, December 12th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $44.40.

Get Our Latest Stock Report on PACS

PACS Group Stock Performance

PACS Group stock traded up $1.25 during midday trading on Wednesday, reaching $38.12. The stock had a trading volume of 133,344 shares, compared to its average volume of 1,096,220. PACS Group has a 12 month low of $7.50 and a 12 month high of $43.08. The firm’s 50-day moving average price is $38.17 and its 200 day moving average price is $24.80. The firm has a market capitalization of $5.99 billion, a PE ratio of 30.99, a P/E/G ratio of 1.26 and a beta of -0.64. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.28.

Institutional Investors Weigh In On PACS Group

Several large investors have recently added to or reduced their stakes in the business. Cubist Systematic Strategies LLC bought a new position in PACS Group in the 1st quarter worth about $198,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of PACS Group by 6.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,280 shares of the company’s stock worth $262,000 after purchasing an additional 1,443 shares in the last quarter. Millennium Management LLC increased its position in shares of PACS Group by 68.3% in the first quarter. Millennium Management LLC now owns 859,295 shares of the company’s stock worth $9,658,000 after purchasing an additional 348,743 shares during the last quarter. Jones Financial Companies Lllp bought a new position in shares of PACS Group in the first quarter worth approximately $64,000. Finally, Caxton Associates LLP purchased a new stake in PACS Group in the first quarter valued at approximately $163,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Further Reading

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.